LON:SYNC Syncona (SYNC) Share Price, News & Analysis GBX 93.30 0.00 (0.00%) As of 05/15/2026 11:51 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesBuy This Stock About Syncona Stock (LON:SYNC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Syncona alerts:Sign Up Key Stats Today's Range 92.60▼ 9450-Day Range 86.90▼ 9652-Week Range 79.60▼ 102.60Volume441,346 shsAverage Volume697,758 shsMarket Capitalization£567.44 millionP/E RatioN/ADividend Yield1.04%Price TargetGBX 189Consensus RatingBuy Company Overview Syncona's purpose is to invest to extend and enhance human life. We do this by creating, building and scaling companies to deliver transformational treatments to patients in areas of high unmet need. We aim to build and maintain a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic area, for the benefit of all our stakeholders. We focus on developing treatments that deliver patient impact by working in close partnership with world-class academic founders and experienced management teams. Our balance sheet underpins our strategy, enabling us to take a long-term view as we look to improve the lives of patients with no or poor treatment options, build sustainable life science companies and deliver strong risk-adjusted returns to shareholders. Read More Receive SYNC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Syncona and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SYNC Stock News HeadlinesSyncona Investment Management Limited ("SIML"): Syncona Investment Management Limited highlights progress translating frontier science into therapeutic reality at Capital ...March 19, 2026 | finanznachrichten.deSyncona Investment Management Limited highlights progress translating frontier science into therapeutic reality at Capital Markets DayMarch 19, 2026 | finance.yahoo.com$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…May 17 at 1:00 AM | Paradigm Press (Ad)Syncona Wins Shareholder Backing for New Investment Policy and Board RefreshMarch 3, 2026 | tipranks.comSyncona’s Quell Therapeutics Advances Lead CAR-Treg Autoimmune Therapy and Refocuses PipelineMarch 3, 2026 | tipranks.comSyncona hails biotech recovery ahead of dividend policy voteFebruary 5, 2026 | lse.co.uk2 compelling FTSE 250 stocks tipped to grow 100% (or more) in the coming yearFebruary 5, 2026 | uk.finance.yahoo.comSyncona Ups Beacon Therapeutics Stake as Gene Therapy Group Raises $75m Series CJanuary 8, 2026 | tipranks.comSee More Headlines SYNC Stock Analysis - Frequently Asked Questions How have SYNC shares performed this year? Syncona's stock was trading at GBX 95 at the beginning of 2026. Since then, SYNC stock has decreased by 1.8% and is now trading at GBX 93.30. How do I buy shares of Syncona? Shares of SYNC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Syncona own? Based on aggregate information from My MarketBeat watchlists, some other companies that Syncona investors own include Petrofac (PFC), Reckitt Benckiser Group (RKT), Barclays (BARC), B&M European Value Retail (BME), BP (BP), genedrive (GDR) and Vodafone Group Public (VOD). Industry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:SYNC Previous SymbolLON:BACT CIKN/A Webwww.bacitltd.com Phone17168531362FaxN/AEmployees1,208Year FoundedN/APrice Target and Rating Average Price Target for SynconaGBX 189 High Price TargetGBX 189 Low Price TargetGBX 189 Potential Upside/Downside+102.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)GBX (15.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£16.90 million Net Margins-145.42% Pretax MarginN/A Return on Equity-9.02% Return on Assets0.40% Debt Debt-to-Equity RatioN/A Current Ratio0.02 Quick Ratio0.53 Sales & Book Value Annual Sales-£14.05 million Price / Sales-40.38 Cash FlowGBX 79.44 per share Price / Cash Flow1.17 Book ValueGBX 177.06 per share Price / Book0.53Miscellaneous Outstanding Shares608,193,000Free FloatN/AMarket Cap£567.44 million OptionableNot Optionable Beta0.31 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free Report This page (LON:SYNC) was last updated on 5/17/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX Goes Public. Here's What Happens To Your IRA.When SpaceX goes public, fund managers will sell existing portfolio holdings to fund the move. Trillions in as...Americas Gold Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syncona Please log in to your account or sign up in order to add this asset to your watchlist. Share Syncona With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
